Login/Sign Up
₹59450*
MRP ₹72500
18% off
₹61625*
MRP ₹72500
15% CB
₹10875 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Whats That
Country of origin
Alcohol
Consult your doctor
It is unknown whether Yervoi 5 mg/ml Infusion 10 ml interacts with alcohol. Consult your doctor.
Pregnancy
Unsafe
Yervoi 5 mg/ml Infusion 10 ml is not recommended for use in pregnancy as it may cause embryo-fetal toxicity and harm your foetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before taking Yervoi 5 mg/ml Infusion 10 ml. You should not become pregnant while you are taking Yervoi 5 mg/ml Infusion 10 ml for at least 3 months from the last dose of Yervoi 5 mg/ml Infusion 10 ml. Using effective birth control methods while on treatment with Yervoi 5 mg/ml Infusion 10 ml is suggested.
Breast Feeding
Unsafe
Inform your doctor if you are intending to breastfeed. Breastfeeding should be avoided while getting Yervoi 5 mg/ml Infusion 10 ml and for 3 months following the final dosage.
Driving
Not applicable
Yervoi 5 mg/ml Infusion 10 ml will be administered to hospitalized patients.
Liver
Caution
If you have a pre-existing or a history of liver problems, tell your doctor before taking this medicine. Yervoi 5 mg/ml Infusion 10 ml is known to cause hepatotoxicity when taken in combination with nivolumab. Notify your doctor if you notice any of the following symptoms: yellowing of your skin or whites of your eyes; severe nausea or vomiting; pain on the right side of your stomach (abdomen); dark urine (tea-coloured); easier bleeding or bruising than usual. Your doctor may suggest tests to monitor your liver function while on treatment with this medicine.
Kidney
Caution
If you have a pre-existing or a history of kidney diseases, inform your doctor before taking Yervoi 5 mg/ml Infusion 10 ml. It may cause kidney injury. Notify your doctor if you experience symptoms such as decreased urine output, blood in your urine, ankle edema, or lack of appetite.
Children
Unsafe
Yervoi 5 mg/ml Infusion 10 ml is not recommended for use in children below 12 years, as the safety and efficacy have not been established.
Keep Refrigerated. Do not freeze.Prepaid payment required.
About Yervoi 5 mg/ml Infusion 10 ml
Yervoi 5 mg/ml Infusion 10 ml is an anti-cancer medicine used in the treatment of various types of cancers. Cancer is a disease caused by the abnormal growth of cells that divide uncontrollably. This medicine is used in treating metastatic melanoma, advanced renal cell carcinoma in combination with nivolumab, hepatocellular carcinoma in patients who have previously been treated with sorafenib, colorectal cancer, metastatic non-small cell lung cancer, and malignant pleural mesothelioma.
Yervoi 5 mg/ml Infusion 10 ml contains Ipilimumab, which belongs to the class of CTLA-4 monoclonal antibody. It works by inhibiting the action of a human cytotoxic T-lymphocyte antigen 4 molecule, thereby stopping the abnormal growth of cancer cells.
Yervoi 5 mg/ml Infusion 10 ml may cause certain side effects such as diarrhoea, decreased appetite, nausea, vomiting, tiredness, itching, rash, headache, fever, decreased weight, and dizziness. Inform your doctor if any of these side effects bother you. Yervoi 5 mg/ml Infusion 10 ml will be administered by an oncologist with experience in administering chemotherapeutic agents in the hospital setting. Avoid self-administration.
If you are allergic to Yervoi 5 mg/ml Infusion 10 ml or its components, inform your doctor. Before taking Yervoi 5 mg/ml Infusion 10 ml, inform your doctor if you have/had liver or kidney disease, autoimmune disorders such as ulcerative colitis, Crohn’s disease, or a history of organ transplants. This medicine is known to cause embryo-fetal toxicity. Hence, it is not recommended for use in pregnancy. If you are breastfeeding, inform your doctor before receiving Yervoi 5 mg/ml Infusion 10 ml.
Uses of Yervoi 5 mg/ml Infusion 10 ml
Medicinal Benefits
Yervoi 5 mg/ml Infusion 10 ml contains Ipilimumab, which is used in treating different types of cancers. It works by inhibiting the action of a human cytotoxic T-lymphocyte antigen 4 molecule (CTLA-4) that causes the multiplication of cancerous cells. This helps stop the abnormal growth of cancer cells and thus reduce the further spread to other parts of the body. In this way, Yervoi 5 mg/ml Infusion 10 ml stops the body's production, spread and growth of cancerous cells.
Directions for Use
Side Effects of Yervoi 5 mg/ml Infusion 10 ml
Drug Warnings
To treat your condition effectually, continue taking Yervoi 5 mg/ml Infusion 10 ml for the period that your doctor has prescribed. Yervoi 5 mg/ml Infusion 10 ml may cause severe immune-mediated adverse reactions (IMAR) such as immune-mediated colitis, hepatitis, nephritis, endocrinopathies, pneumonitis, and dermatologic reactions. It may also cause infusion-related reactions in some patients. Discontinue the treatment if any severe infusion reactions occur. Inform your doctor if you are pregnant or are planning to become pregnant before starting the treatment, as this medicine is known to cause embryo-fetal toxicity. Caution should be exercised if you have/had liver or kidney disease, any history of organ transplant, gastrointestinal disorders and autoimmune disorders such as ulcerative colitis or Crohn’s disease while receiving Yervoi 5 mg/ml Infusion 10 ml. Breastfeeding should be discontinued in nursing mothers during the treatment as it passes into breast milk and may cause a possible risk to the infant. This medicine is not recommended for use in children below 12 years of age as the safety and efficacy are not established.
Drug-Drug Interactions
Drug-Food Interactions
Drug-Diseases Interactions
Drug-Drug Interactions Checker List
Habit Forming
Special Advise
Diet & Lifestyle Advise